![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 48/00 | |
C07H 21/02 | |||
C07H 21/04 |
(11) | Number of the document | 2763701 |
(13) | Kind of document | T |
(96) | European patent application number | 12838676.0 |
Date of filing the European patent application | 2012-10-03 | |
(97) | Date of publication of the European application | 2014-08-13 |
(45) | Date of publication and mention of the grant of the patent | 2018-12-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2012/058519 |
Date | 2012-10-03 |
(87) | Number | WO 2013/052523 |
Date | 2013-04-11 |
(30) | Number | Date | Country code |
201161542533 P | 2011-10-03 | US |
(72) |
DE FOUGEROLLES, Antonin, US
ROY, Atanu, US
SCHRUM, Jason P., US
SIDDIQI, Suhaib, US
HATALA, Paul, US
BANCEL, Stephane, US
|
(73) |
Moderna Therapeutics, Inc.,
320 Bent Street, Cambridge, Massachusetts 02141,
US
|
(54) | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF |
MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF |